Evidence map›Paper›PMID 35092553›Full record

ArticleLifetime data analysis2022

Scalable proximal methods for cause-specific hazard modeling with time-varying coefficients.

Wenbo Wu, Jeremy M G Taylor, Andrew F Brouwer, Lingfeng Luo, Jian Kang, Hui Jiang, Kevin He

Abstract read
In one paragraph

Article in Lifetime data analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Models and methods for analysing clustered recurrent hospitalisations in the presence of COVID-19 effects.Journal of the Royal Statistical Society. Series C, Applied statistics · 2024
    Article
  4. Competing Risk Modeling with Bivariate Varying Coefficients to Understand the Dynamic Impact of COVID-19.Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America · 2024
    Article
  5. surtvep: An R package for estimating time-varying effects.Journal of open source software · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenbo WuDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Jeremy M G TaylorDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Andrew F BrouwerDepartment of Epidemiology, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Lingfeng LuoDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Jian KangDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Hui JiangDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA.
Kevin HeDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, MI, 48109-2029, USA. kevinhe@umich.edu.ORCID 0000-0002-8354-426X

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Modeling Precision Interventions for Prostate Cancer ControlU01CA253915 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ETZIONI, RUTH D, TSODIKOV, ALEXANDER · 2020 to 2025
$6.5M
NCATS NIH HHS UL1 TR002240NCI NIH HHS P30 CA046592NCI NIH HHS U01 CA253915
6 · The paper itself

Abstract

Survival modeling with time-varying coefficients has proven useful in analyzing time-to-event data with one or more distinct failure types. When studying the cause-specific etiology of breast and prostate cancers using the large-scale data from the Surveillance, Epidemiology, and End Results (SEER) Program, we encountered two major challenges that existing methods for estimating time-varying coefficients cannot tackle. First, these methods, dependent on expanding the original data in a repeated measurement format, result in formidable time and memory consumption as the sample size escalates to over one million. In this case, even a well-configured workstation cannot accommodate their implementations. Second, when the large-scale data under analysis include binary predictors with near-zero variance (e.g., only 0.6% of patients in our SEER prostate cancer data had tumors regional to the lymph nodes), existing methods suffer from numerical instability due to ill-conditioned second-order information. The estimation accuracy deteriorates further with multiple competing risks. To address these issues, we propose a proximal Newton algorithm with a shared-memory parallelization scheme and tests of significance and nonproportionality for the time-varying effects. A simulation study shows that our scalable approach reduces the time and memory costs by orders of magnitude and enjoys improved estimation accuracy compared with alternative approaches. Applications to the SEER cancer data demonstrate the real-world performance of the proximal Newton algorithm.

Indexed as

Prostatic NeoplasmsAlgorithmsHumansMaleSample SizeSEER ProgramBreast cancerB-splineKronecker productParallel computingProstate cancerProximal algorithm

Identifiers

PMID35092553
PMCPMC9201734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.